π΅οΈ Janux Therapeutics, Inc. ($JANX)
SEC insider & ownership activity, last 12 months Β· CIK 1817713 Β· every row links its SEC filing
Over the last 12 months insiders sold $1.1M with no open-market buying against it. Andy Meyer sold $737K through a 10b5-1 trading plan in 5 lots (OctβJan). No red-flag 8-Ks in the window.
π¨ 3 signals active β
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) Β· 7 sellers, $1.1M (12 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Andy Meyer | 0 | β | 5 | $737K | Jan 2, 2026 |
| Campbell David Alan | 0 | β | 1 | $111K | Jan 2, 2026 |
| Doyle Janeen Noel | 0 | β | 1 | $57K | Jun 2, 2026 |
| Dobek Maria | 0 | β | 2 | $49K | May 11, 2026 |
| Zachariah A. McIver | 0 | β | 1 | $37K | Jan 2, 2026 |
| Diraimondo Thomas | 0 | β | 1 | $34K | Jan 2, 2026 |
| Charles M. Winter | 0 | β | 1 | $33K | Jan 2, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | 19.9% | 13D | Mar 6, 2025 | filing β | |
| Peter Kolchinsky | 19.9% | 13D | Mar 6, 2025 | filing β | |
| Rajeev Shah | 19.9% | 13D | Mar 6, 2025 | filing β | |
| RA Capital Healthcare Fund, L.P. | 18.2% | 13D | Mar 6, 2025 | filing β | |
| BlackRock, Inc. | 6.7% | 13G | Jul 28, 2026 | filing β | |
| W. Lawrence Hawkins | 5.3% | 13G | Feb 6, 2026 | filing β | |
| Prosight Management, LP | 5.2% | 13G | Feb 6, 2026 | filing β | |
| Prosight Partners, LLC | 5.2% | 13G | Feb 6, 2026 | filing β |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Janeen Noel Doyle | $57K | Jun 2, 2026 | filing β |
| Andy Meyer | $28K | Apr 13, 2026 | filing β |
| Zachariah A. McIver | $1.1M | Apr 2, 2026 | filing β |
| Andy Meyer | $2.6M | Jan 26, 2026 | filing β |
| Andy Meyer | $1.7M | Jan 23, 2026 | filing β |
| Byron C. Robinson | $258K | Dec 15, 2025 | filing β |
| Byron C. Robinson | $826K | Dec 8, 2025 | filing β |
| Byron C. Robinson | $1.0M | Dec 2, 2025 | filing β |
| Andrew Meyer | $114K | Dec 1, 2025 | filing β |
| Andrew Meyer | $92K | Nov 14, 2025 | filing β |
| Andrew Meyer | $456K | Oct 28, 2025 | filing β |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 6, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Aug 6, 2026 | filing β |
| Other events (8.01) | Jun 23, 2026 | filing β |
| Shareholder vote (5.07) | Jun 11, 2026 | filing β |
| Earnings (2.02) | May 7, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing β |
| Officer/director changes (5.02) | Apr 28, 2026 | filing β |
| Earnings (2.02) | Feb 26, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing β |
| Material agreement (1.01) | Jan 21, 2026 | filing β |
| Reg FD disclosure (7.01) | Jan 21, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jan 21, 2026 | filing β |
| Earnings (2.02) | Nov 6, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing β |
| Officer/director changes (5.02) | Sep 18, 2025 | filing β |